kidney disease

9 Newly Approved Novel Drugs
9 Newly Approved Novel DrugsIt's still early in 2017, but the FDA has been approving drugs left and right. Here's what you need to know.
New bladder cancer, kidney disease therapies availableFDA recently approved 2 new therapies: an expanded drug indication for locally advanced or metastatic urothelial carcinoma (mUC) and a treatment for secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis.
Five ways care management can shift to value-based careAs fee-for-service rapidly transforms into value-based care, the industry must improve member engagement and outcomes by using targeted care management interventions that help deliver bottom-line results across a broader spectrum of the population.
Medicare Part D patients not taking blood pressure meds correctlyExpert offers specific actions for managed care execs to take
FDA approves novel kidney disease drugAfter initially rejecting calcifediol (Rayaldee, Opko Health) for chronic kidney disease earlier this year because of manufacturing concerns, FDA approved the drug four months ahead of its new timeline. Rayaldee extended release capsules is the first drug to receive FDA approval for the treatment of secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and serum total 25-hydroxyvitamin D levels less than 30 ng/mL.
CDC declares Zika virus teratogenicThe Centers for Disease Control and Prevention have declared Zika teratogenic. Also, a look at whether the HPV vaccine is as effective in women with kidney disease. Plus: What impact does cannabis have on adverse outcomes for mom and baby?
Landmark study: Intensive blood pressure management may save livesAn NIH-sponsored trial enrolled more than 9,300 participants ages 50 and older with high blood pressure. View the results.
FDA drug approvals-January 2015FDA actions in brief, recommendations for approval, fast-track designations.
FDA approves oral iron-based treatment for dialysis patients with hyperphosphatemiaFDA has approved Ferric Citrate (Keryx), an oral, iron-based therapy for the control of serum phosphorus levels in chronic kidney disease (CKD) patients on dialysis.
FDA drug approvals-August 2014FDA actions in brief, complete response, fast-track designation, priority review, orphan drug designations, first-time generic approval